 
        Efficacy of pregabalin for immediate postoperative pain and opioid consumption after THA
 
                                                    Efficacy of pregabalin for immediate postoperative pain and opioid consumption after THA
Pregabalin reduces postoperative opioid consumption and pain for 1 week after hospital discharge, but does not affect function at 6 weeks or 3 months after total hip arthroplasty
Br J Anaesth. 2015 Dec;115(6):903-11Synopsis
184 patients scheduled for total hip arthroplasty were randomized to receive a predetermined perioperative analgesic regimen (spinal anesthesia and celecoxib) with or without the addition of pregabalin. The purpose of this study was to analyze the benefits of pregabalin when compared to a placebo in terms of pain, function and postoperative opioid consumption. The results of this study demonstrate...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.